US approval of Alzheimer's drug offers hope to patients in S'pore too

SPH Brightcove Video
Biogen said on Tuesday it expects to begin shipping its newly approved Alzheimer's drug Aduhelm in about two weeks.
New: Gift this subscriber-only story to your friends and family

United States regulators have for the first time approved a drug that can slow the progression of Alzheimer's disease, the most common type of dementia, offering hope for the growing pool of such patients here as well.

Current medications are able to treat just the symptoms of Alzheimer's, a disease which robs patients of their memory and cognitive abilities as the cells in their brains that process, store and retrieve information degenerate and die.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's WhatsApp Channel and get the latest news and must-reads.